The insider buying is too small to be material. Focus on the underlying business fundamentals from the Q1 earnings report, guidance was cut, and the stock may face headwinds. Monitor for larger insider transactions or further corporate developments.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 29 $91.35entry
- T+1 · 7mo ago −0.79%α −1.81% · $90.63
- T+5 · 6mo ago −5.62%α −8.73% · $86.22
- T+20 · 6mo ago −5.60%α −11.64% · $86.24
- T+60 · 4mo ago +10.29%α +6.56% · $100.75
Price Chart
How similar events traded
Executive Summary
Insider cluster at Abbott Laboratories shows two open-market purchases totaling $1.13M by the CFO and a director, plus routine non-cash grants to directors. The total cash buying represents only 0.0007% of the company's $161.6B market cap, making it economically trivial. The cluster follows a bearish earnings report on April 16 that lowered full-year guidance, but the insider buying is too small to signal confidence.
Key Financial Metrics
Key Facts
- CFO Philip Boudreau purchased $201,300 worth of shares on April 23 at $91.50
- Director Daniel Starks purchased $926,537 worth of shares on April 27 at $92.65
- 14 other insider transactions were non-cash grants (code A) or discretionary trades (code I), totaling $0 in open-market purchases
- Total cash purchases: ~$1.13M, 0.0007% of market cap
- Cluster occurred 7-11 days after a bearish Q1 earnings miss and guidance cut
Financial Impact
Negligible; $1.13M in insider buying is trivial relative to $161.6B market cap
Risk Factors
- No material risks from this cluster; the buying is immaterial
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ABT-1777419507088 |
Track record
38 reports on ABT
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +17.16% at T+20 after the Jul 1, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $109.93 Now $107.45 −2.26% settles Dec 7
- Oct 27, 202620d ago ANALYST-DOWNGRADE Neutral 2/10 Entry $103.10 Now $107.45 +4.22% settles Nov 24
- Oct 27, 202620d ago Court Ruling Neutral 1/10 Entry $102.64 Now $107.45 +4.69% settles Nov 25
- Oct 21, 202626d ago Institutional Cluster Mixed 4/10 Entry $102.51 Now $107.45 +4.82% settles Nov 19
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 21, 202626d ago 8-K Bearish 6/10 No price data
- Oct 21, 202626d ago Press Release Neutral 4/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 20, 202627d ago Court Ruling Neutral 1/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 16, 20264w ago Court Ruling Neutral 2/10 Entry $104.06 to $107.45 Now $107.45 +3.26% ▲ +3.26% +6.72% vs SPY
- Oct 15, 20264w ago Court Ruling Bullish 5/10 Entry $104.89 to $108.52 Now $107.45 +2.44% ▲ +3.46% +4.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers